These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2199281)

  • 21. Comparative pharmacokinetics and glucodynamics of two human insulin mixtures. 70/30 and 50/50 insulin mixtures.
    Woodworth JR; Howey DC; Bowsher RR; Brunelle RL; Rowe HM; Compton J; Cerimele B
    Diabetes Care; 1994 May; 17(5):366-71. PubMed ID: 8062601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The action profiles of human NPH insulin preparations.
    Starke AA; Heinemann L; Hohmann A; Berger M
    Diabet Med; 1989 Apr; 6(3):239-44. PubMed ID: 2523785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique.
    Scholtz HE; Pretorius SG; Wessels DH; Becker RH
    Diabetologia; 2005 Oct; 48(10):1988-95. PubMed ID: 16160867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of the euglycaemic clamp technique to bioassay of insulin analogues.
    Vłlund A; Ribel U; Dam PL; Markussen J; Langkjaer L; Dolben J; Owens DR
    Biologicals; 1992 Jun; 20(2):135-42. PubMed ID: 1389109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.
    Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L
    Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose infusion rates during euglycaemic clamps do not precisely reflect action profiles of subcutaneously injected insulin.
    Kerner W; Keck FS; Pfeiffer EF
    Diabetologia; 1991 Jan; 34(1):60-1. PubMed ID: 2055344
    [No Abstract]   [Full Text] [Related]  

  • 27. Establishment of time-action profiles for regular and NPH insulin using pharmacodynamic modeling.
    Woodworth JR; Howey DC; Bowsher RR
    Diabetes Care; 1994 Jan; 17(1):64-9. PubMed ID: 8112192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes.
    Luzio S; Dunseath G; Peter R; Pauvaday V; Owens DR
    Diabetologia; 2006 Jun; 49(6):1163-8. PubMed ID: 16596358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal activity profiles of NPH and [Nepsilon-palmitoyl Lys (B29)] human insulins in subjects with IDDM.
    Radziuk J; Pye S; Bradley B; Braaten J; Vignati L; Roach P; Bowsher R; DiMarchi R; Chance R
    Diabetologia; 1998 Jan; 41(1):116-20. PubMed ID: 9498640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble and Lente human insulin mixtures in normal man.
    Owens DR; Vora JP; Jones IR; Birtwell J; Atiea J; Luzio S; Williams S
    Diabetes Res; 1988 Jan; 7(1):35-40. PubMed ID: 3042252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The action profile of lispro is not blunted by mixing in the syringe with NPH insulin.
    Joseph SE; Korzon-Burakowska A; Woodworth JR; Evans M; Hopkins D; Janes JM; Amiel SA
    Diabetes Care; 1998 Dec; 21(12):2098-102. PubMed ID: 9839100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semisynthetic human insulin: pharmacokinetics and biological potency in healthy subjects in comparison with highly purified porcine insulin.
    Schulz B; Stöwhas H; Becker R; Steinicke A; Besch W
    Exp Clin Endocrinol; 1988 Mar; 92(3):307-13. PubMed ID: 3075554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rat C peptide I and II stimulate glucose utilization in STZ-induced diabetic rats.
    Li L; Oshida Y; Kusunoki M; Yamanouchi K; Johansson BL; Wahren J; Sato Y
    Diabetologia; 1999 Aug; 42(8):958-64. PubMed ID: 10491756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacology of human insulin of recombinant DNA origin in healthy volunteers.
    Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Tarui S
    Diabetes Care; 1982; 5 Suppl 2():35-8. PubMed ID: 6765537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects.
    Kang S; Creagh FM; Peters JR; Brange J; Vølund A; Owens DR
    Diabetes Care; 1991 Jul; 14(7):571-7. PubMed ID: 1914797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of the activity of biosynthetic human insulin and pork insulin using the glucose clamp technique in normal subjects.
    Massi-Benedetti M; Burrin JM; Capaldo B; Alberti KG
    Diabetes Care; 1981; 4(2):163-7. PubMed ID: 7011718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the pharmacodynamic profiles of insulin detemir and insulin glargine: a single dose clamp study in people with type 2 diabetes.
    Luzio SD; Dunseath GJ; Atkinson MD; Owens DR
    Diabetes Metab; 2013 Dec; 39(6):537-42. PubMed ID: 24139704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GLP-1 does not not acutely affect insulin sensitivity in healthy man.
    Orskov L; Holst JJ; Møller J; Orskov C; Møller N; Alberti KG; Schmitz O
    Diabetologia; 1996 Oct; 39(10):1227-32. PubMed ID: 8897012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
    Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
    Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
    Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
    Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.